Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)

Summary

Renal failure patients were treated with linezolid (LZD) for proven or suspected infections by multiresistant Gram-positive cocci. The aim of this study is to determine if dose adjustment of LZD is needed as a function of renal impairment or not, especially that a significant component of LZD is eliminated unchanged in urine.

Timeline

Start

2013-10

Primary completion

2014-01

Completion

2014-01

Drugs

Indications